Get it on Google Play

EpiCept (EPCT) Responds to Negative Opinion From EMEA for Ceplene

March 20, 2008 12:37 PM EDT Send to a Friend
EpiCept Corporation (Nasdaq: EPCT) announced that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login